8.72
+3.20%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Daxor
From its filings with the US Securities and Exchange Commission
Daxor is based in Oak Ridge, Tennessee and is incorporated in New York. Its shares trade on Nasdaq under the ticker DXR. In the fiscal year to 31 December 2011, it reported revenue of $1.4m and a net loss of $7.2m. At that date it held total assets of $85.7m and shareholders' equity of $36.2m.
(DORO) facility in Oak Ridge, TN, which manufactures, tests, and develops next-generation models of the BVA-100 ® .
2012, the SEC notified the Company that the request to withdraw the petition for review and notice of finality had been approved.
90 minutes. In emergency situations, preliminary results can be available within just 20 to 25 minutes.
Shevde K, Pagala M, Tyagaraj C et al. Preoperative Blood Volume Deficit Influences Blood Transfusion Requirements in Females and Males Undergoing Coronary Bypass Graft Surgery. J Clin Anesth . 2002; 14:512-517.
Alrawi SJ, Miranda LS, Cunningham JN et al. Correlation of Blood Volume Values and Pulmonary Artery Catheter Measurements. Saudi Med J . 2002; 23:1367-1372.
Androne AS, Katz SD, Lund L et al. Hemodilution is Common in Patients with Advanced Heart Failure. Circulation . 2003; 107:226-229.
James KB, Stelmach K, Armstrong R et al. Plasma Volume and Outcome in Pulmonary Hypertension. Tex Heart Inst J . 2003; 30:305-307.
Mancini DM, Katz SD, Lang CC et al. Effect of Erythropoietin on Exercise Capacity in Patients with Moderate to Severe Chronic Heart Failure. Circulation . 2003; 107:294-299.
Quoted from its 10-K, filed 28 Mar 2012. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 25 Jul 1983
- Website
- daxor.com ↗
- Head office
- 107 MECO LANE, OAK RIDGE, TN, 37830
- Incorporated in
- NY
Leadership
Pay as last reported
- Mr. Michael FeldschuhChairman of the Board, President, Chief Executive Officer, since 2013$101,002
- Mr. Robert MichelChief Financial Officer, Chief Compliance Officer, Corporate Secretary$151,507
- Mr. Jonathan FeldschuhChief Scientific Officer, Director, since 2016$129,205
- Mr. John JefferiesChief Medical Officer$160,614
- Dr. Henry CremisiIndependent Director$1,750
- Mr. Caleb DesrosiersIndependent Director$1,750
- Mr. Edward FeuerIndependent Director$1,750
- Ms. Joy GoudieIndependent Director$750
- Mr. Bret ShapiroIR Contact Officer, since 2021
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Daxor Corp develops and manufactures the BVA-100 blood volume analyzer.
- The BVA-100 is FDA-cleared for measuring blood volume status and composition.
- Over 65,000 tests have been performed at U.S. hospital centers.
Weaknesses
- The company is a biotechnology firm with limited public information on financial performance.
- The source description treats the company as untrusted, indicating potential reliability issues.
- No specific details on market share or competitive advantages are provided.
Opportunities
- Ongoing NIH-supported trials in heart failure treatment could expand market opportunities.
- The company is under contract for developing analyzers, potentially leading to new revenue streams.
- Advancing healthcare through blood volume analysis may attract further partnerships.
Threats
- The source description is untrusted, which may affect credibility and investor confidence.
- The company's focus on a single product (BVA-100) could pose risks if market demand shifts.
- Reliance on hospital centers for test performance may limit scalability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.